{"id":2138,"date":"2017-08-25T14:35:18","date_gmt":"2017-08-25T12:35:18","guid":{"rendered":"https:\/\/www.europlasma.com\/investisseurs-et-actionnaires\/espace-actionnaires\/"},"modified":"2022-05-03T11:36:13","modified_gmt":"2022-05-03T09:36:13","slug":"espace-actionnaires","status":"publish","type":"page","link":"https:\/\/www.europlasma.com\/en\/investisseurs-et-actionnaires\/espace-actionnaires\/","title":{"rendered":"Shareholders section"},"content":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;left-t-right&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/2&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; el_class=&#8221;bloc-neg&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;4\/6&#8243;]<div id=\"ultimate-heading-570469e9fa8ce2db9\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-570469e9fa8ce2db9 uvc-2257 \" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-570469e9fa8ce2db9 h2'  data-responsive-json-new='{\"font-size\":\"desktop:30px;\",\"line-height\":\"desktop:36px;\"}' ><h2 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#1e3640;margin-top:0px;margin-bottom:0px;\">DIFFERENT SHAREHOLDING METHODS<\/h2><\/div><\/div>[vc_separator sep_color=&#8221;color-dfgh&#8221; icon_position=&#8221;left&#8221; el_width=&#8221;60px&#8221; el_height=&#8221;1px&#8221; el_class=&#8221;margin-20-0-0&#8211;20&#8243;]<div id=\"ultimate-heading-317569e9fa8ce2e3d\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-317569e9fa8ce2e3d uvc-3730 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-317569e9fa8ce2e3d .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:30px;margin-bottom:0px;\">YOU HAVE THE CHOICE BETWEEN SEVERAL METHODS<br \/>\nFOR HOLDING YOUR EUROPLASMA SHARES.<\/div><\/div><div id=\"ultimate-heading-66569e9fa8ce2eaa\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-66569e9fa8ce2eaa uvc-5304 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-66569e9fa8ce2eaa .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:30px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:30px;margin-bottom:0px;\"><strong>&#8220;Bearer&#8221;<\/strong>: Your securities are registered with the financial intermediary of your choice. This system which allows you to group together all the securities in your portfolio within the same account, does not enable Europlasma to identify you.<\/p>\n<p><strong>&#8220;Registered&#8221;<\/strong>: Your securities are registered with Europlasma. You are therefore known by name and registered with the company, which enables you to benefit from a more personalised service.<\/div><\/div>[\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;right-t-left&#8221; width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;440&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221; el_class=&#8221;img-neg-zindex&#8221;][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;left-t-right&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;444&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221; el_class=&#8221;img-neg-zindex&#8221;][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;right-t-left&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/2&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; el_class=&#8221;bloc-neg-left&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;4\/6&#8243;][vc_separator sep_color=&#8221;color-dfgh&#8221; icon_position=&#8221;left&#8221; el_width=&#8221;60px&#8221; el_height=&#8221;1px&#8221; el_class=&#8221;margin-20-0-0&#8211;20&#8243;]<div id=\"ultimate-heading-104069e9fa8ce2f14\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-104069e9fa8ce2f14 uvc-4864 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-104069e9fa8ce2f14 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:30px;margin-bottom:0px;\">THERE ARE TWO METHODS FOR REGISTRATION :<\/div><\/div><div id=\"ultimate-heading-403369e9fa8ce2f7d\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-403369e9fa8ce2f7d uvc-2819 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-403369e9fa8ce2f7d .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:30px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:30px;margin-bottom:0px;\"><strong>Directly registered<\/strong> : your shares are registered and kept in your name within Europlasma&#8217;s record. The company delegates the management of this to Caceis Corporate Trust.<\/p>\n<p><strong>Administered registered<\/strong> : your shares are registered with a financial establishment which assures the management of your securities account and remains your main point of contact. In order for your shares to be registered, your custodian account holder will inform the Caceis Corporate Trust of any changes which will affect your assets and\/or your contact details. You are therefore known to the company.<\/div><\/div>[\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1503669443790{margin-top: 90px !important;margin-bottom: 70px !important;}&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/1&#8243;][vc_separator sep_color=&#8221;color-dfgh&#8221; icon_position=&#8221;left&#8221; el_width=&#8221;60px&#8221; el_height=&#8221;2px&#8221;]<div id=\"ultimate-heading-813969e9fa8ce2fe3\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-813969e9fa8ce2fe3 uvc-9297 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-813969e9fa8ce2fe3 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:30px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:30px;margin-bottom:0px;\">The rules referred to above apply to all holders of transferable securities whether they are French nationals or from abroad. A person residing abroad must therefore ask the company or a qualified intermediary to register his securities in his name.<\/p>\n<p>In order that the vote expressed for the securities concerned may be taken into account, the intermediary needs to declare itself as the &#8220;registered intermediary&#8221; when any accounts are opened, by disclosing its capacity as the intermediary holding securities on behalf of others.<\/div><\/div>[vc_accordion active_tab=&#8221;active&#8221; el_class=&#8221;toggle-avantages&#8221;][vc_accordion_tab title=&#8221;ADVANTAGES AND DISADVANTAGES OF DIFFERENT SHAREHOLDING METHODS&#8221; tab_id=&#8221;1503667837-1-8&#8243;][vc_row_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;]<div id=\"ultimate-heading-127769e9fa8ce304c\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-127769e9fa8ce304c uvc-1688 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-127769e9fa8ce304c .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:12px;\",\"line-height\":\"desktop:18px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table style=\"width: 100%;\" border=\"0\">\n<tbody>\n<tr>\n<td valign=\"top\"><\/td>\n<td style=\"text-align: center; background-color: #bbbbbb;\" align=\"center\" valign=\"middle\"><strong>Directly<br \/>\nregistered<\/strong><\/td>\n<td style=\"text-align: center; background-color: #bbbbbb;\" align=\"center\" valign=\"middle\"><strong>Adminitered<br \/>\nregistered<\/strong><\/td>\n<td style=\"background-color: #bbbbbb;\" align=\"center\" valign=\"middle\"><strong>Bearer<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Free of general managment fees<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"top\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"top\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"top\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #bbbbbb;\" align=\"left\" valign=\"middle\"><strong>Receipt of General Meeting convening notices and prepartory documents by post<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Registration of securities in a PEP<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Double voting rights (article 12 of the Articles of Association)<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Single portfolio<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;HOW TO TRANSFER YOUR SHARES TO REGISTERED&#8221; tab_id=&#8221;1503667837-2-0&#8243;][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;]<div id=\"ultimate-heading-422669e9fa8ce30b4\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-422669e9fa8ce30b4 uvc-3144 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-422669e9fa8ce30b4 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:12px;\",\"line-height\":\"desktop:18px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:0px;margin-bottom:0px;\"><strong>Directly registered :<\/strong><\/p>\n<p>Simply send the application form for transferring securities to your financial intermediary, duly completed and signed. Your financial intermediary will do what is necessary with the Caceis Corporate Trust (14 rue Rouget de Lisle &#8211; 92189 Issy les Moulineaux).<\/p>\n<p>On receipt of your shares, the Caceis Corporate Trust, a company appointed by Europlasma to manage the registered accounts, will send you the registration certificate for the corresponding account. The Caceis Corporate Trust will therefore become your sole point of contact for your Europlasma securities.<\/p>\n<p>A purchase\/sale advice will also be sent to you after each transaction carried out on your accont. On 31 December of each year, the Caceis Corporate Trust will send you a statement of account of your securities. The fees incurred for the transfer of securities are determined by your financial intermediary. You must therefore refer to the commissions scale applied by them.<\/p>\n<p>To find out the period of time necessary for the transfer of your securities, contact you fiancial intermediary. Registration to a registered account will only be definitive following the effective transfer of your securities by this financial intermediary.<\/div><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;]<div id=\"ultimate-heading-590069e9fa8ce311a\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-590069e9fa8ce311a uvc-246 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-590069e9fa8ce311a .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:12px;\",\"line-height\":\"desktop:18px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:0px;margin-bottom:0px;\"><strong>Administered registered :<\/strong><\/p>\n<p>the shares, held and managed by the shareholder&#8217;s financial intermediary, are also registered with the company&#8217;s securities service (methods particularly recommended where a PEP is held).<\/p>\n<p>Registration of these shares to administered registered does not require the securities to be transferred, or the banking institution to be changed. Your administered registered securities account is therefore managed by the financial institution of your choice.<\/p>\n<p>Your bank manager must complete a registration application (BRN: registered reference note) with Europlasma&#8217;s trustee, i.e. the Caceis Corporate Trust, and will maintain the management of your securities account.<\/p>\n<p>The Caceis Corporate Trust shall proceed with the registration of your securities to adminitered registered, free of charge, on receipt of the application by your financial intermediary. Shares held in a PEP may be registered ad administered registered.<\/div><\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1505210945744{padding-top: 80px !important;padding-bottom: 80px !important;}&#8221; row_name=&#8221;assembleesgenerales&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/1&#8243;]<div id=\"ultimate-heading-921169e9fa8ce3183\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-921169e9fa8ce3183 uvc-5152 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-921169e9fa8ce3183 h2'  data-responsive-json-new='{\"font-size\":\"desktop:30px;\",\"line-height\":\"desktop:36px;\"}' ><h2 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#1e3640;margin-top:0px;margin-bottom:0px;\">GENERAL MEETINGS<\/h2><\/div><\/div>[vc_accordion el_class=&#8221;toggle-assemblees&#8221; active_tab=&#8221;active&#8221;][vc_accordion_tab title=&#8221;Ordinary &amp; Extraordinary General Meeting &#8211; 7 June 2022&#8243; tab_id=&#8221;1651569987371-14-0&#8243;]<div id=\"ultimate-heading-660069e9fa8ce31eb\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-660069e9fa8ce31eb uvc-6305 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-660069e9fa8ce31eb h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-660069e9fa8ce31eb .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of June 7, 2022. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to this General Meeting. <a href=\"https:\/\/www.europlasma.com\/investisseurs-et-actionnaires\/espace-actionnaires\/assemblees-generales\/\" target=\"_blank\" rel=\"noopener\">See all documentation<\/a><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary General Meeting of Shareholders on 8 June 2021 reconvened on 29 June 2021&#8243; tab_id=&#8221;1619164541461-13-6&#8243;]<div id=\"ultimate-heading-679369e9fa8ce3257\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-679369e9fa8ce3257 uvc-3169 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-679369e9fa8ce3257 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-679369e9fa8ce3257 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of June 8, 2021. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to this General Meeting.<\/div><\/div><div id=\"ultimate-heading-650269e9fa8ce32c5\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-650269e9fa8ce32c5 uvc-2111 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-650269e9fa8ce32c5 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-650269e9fa8ce32c5 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO-annonce-2101195.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Participation and vote (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20210518_CP_Mise-\u00e0-disposition-documents_AGO-du-08-06-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-brochure-de-convocation_AGO-08.06.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholder (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO-annonce-2102818.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AGENDA and TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-R\u00e9solutions_AGO-08.06.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2020 Company report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-de-gestion-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">complementary board report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-compl\u00e9mentaire-CA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">special board report on bonus shares<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-AGA-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-224769e9fa8ce3332\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-224769e9fa8ce3332 uvc-2213 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-224769e9fa8ce3332 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-224769e9fa8ce3332 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 FY2020 parent company accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-SA-2020-RCA-CoCAC-27.04.2021..pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on FY2020 consolidated accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-SA-2020-RCC-CoCAC-27.04.2021..pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON REGulated agreements<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-SA-2020-RS-CoCAC-27.04.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-968669e9fa8ce339f\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-968669e9fa8ce339f uvc-3252 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-968669e9fa8ce339f h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-968669e9fa8ce339f .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-par-correspondance-AGO-EUROPLASMA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Answers to writtent questions<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-et-r\u00e9ponses-AGO-29-06-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation OF the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_29-06-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution-3.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">minutes of the general meeting &#8211; 29\/06\/2021<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210629-EP-CR-AG.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting &#8211; 21\/06\/2021<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210608-EP-CR-AG-projet-carence.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting of Shareholders &#8211; 24\/02\/2021&#8243; tab_id=&#8221;1611128617920-12-6&#8243;]<div id=\"ultimate-heading-396769e9fa8ce340b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-396769e9fa8ce340b uvc-7616 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-396769e9fa8ce340b h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-396769e9fa8ce340b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of February 24, 2021. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to this General Meeting.<\/div><\/div><div id=\"ultimate-heading-259169e9fa8ce3477\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-259169e9fa8ce3477 uvc-8527 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-259169e9fa8ce3477 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-259169e9fa8ce3477 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-2_annonce-2100047.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Participation and vote (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20210119_Convocation-AGE-24-f\u00e9vrier.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Ad hoc agent appointment (Press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20210215_D\u00e9signation-mandataire-AGE-24_02_2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AD HOC Certificate<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Attestation-EP-Mandataire.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_avis-de-convocation_SUD-OUEST.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AGENDA and TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-R\u00e9solutions_AGE-24.02.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON general meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210224-EP-Rapport-CA-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-580869e9fa8ce34e3\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-580869e9fa8ce34e3 uvc-2405 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-580869e9fa8ce34e3 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-580869e9fa8ce34e3 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b01<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-co-CAC_1\u00e8re-r\u00e9solution_Emission-actions-et-VM-supp-DPS-au-profit-de-cat\u00e9gories-de-b\u00e9n\u00e9ficiaires.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Complementary report<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-_-Rapport-compl\u00e9mentaire-co-CAC_Emission-actions-et-VM-supp-DPS-au-profit-dune-personne-d\u00e9sign\u00e9e.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-318569e9fa8ce354f\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-318569e9fa8ce354f uvc-1071 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-318569e9fa8ce354f h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-318569e9fa8ce354f .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote_AGE_24.02.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Written questions<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-et-r\u00e9ponses-AGE-24-02-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation OF the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_24-02-2021-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution-2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210224-EP-CR-AGE.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting &#8211; 28\/12\/2020&#8243; tab_id=&#8221;1606142230080-14-0&#8243;]<div id=\"ultimate-heading-278469e9fa8ce35bb\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-278469e9fa8ce35bb uvc-5284 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-278469e9fa8ce35bb h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-278469e9fa8ce35bb .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of December 28, 2020. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to the General Meeting of December 28, 2020.<\/div><\/div><div id=\"ultimate-heading-310369e9fa8ce3627\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-310369e9fa8ce3627 uvc-6552 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-310369e9fa8ce3627 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-310369e9fa8ce3627 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/annonce-2004589.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Participation and vote (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/2020_11_-20-Convocation-AGE-28-d\u00e9cembre.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Appointment of an ad hoc representative (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201209_Designation-mandataire-AGE-28_12_2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Terms for documentation availability and participation (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20201211_CP_Mise-\u00e0-disposition-documents_AGE-du-28-12-2020-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">certificate of ad hoc representative<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201228_Attestation_EP_-_Mandataire.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis_de_convocation_AGM-28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AGENDA and TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Ordre-du-jour-et-texte-des-projets-de-r\u00e9solutions.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON general meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201120-EP-Rapport-CA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-297469e9fa8ce3693\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-297469e9fa8ce3693 uvc-7714 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-297469e9fa8ce3693 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-297469e9fa8ce3693 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b01<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b02<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on resolution n\u00b03<\/td>\n<td style=\"text-align: right; width: 21.3412%;\">\u00a0<a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_3.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b04<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_4.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-89169e9fa8ce36ff\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-89169e9fa8ce36ff uvc-9059 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-89169e9fa8ce36ff h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-89169e9fa8ce36ff .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-par-correspondance.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201228-EP-CR-AGE.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Written questions from Shareholders<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-et-r\u00e9ponses-AGE-28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">How to access the recording<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rediffusion-AGE-28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upolad<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary and Extraordinary General Meeting &#8211; 31\/08\/2020 reconvened on 22\/09\/2020 and 28\/10\/2020 (postponed)&#8221; tab_id=&#8221;1595861352639-13-5&#8243;]<div id=\"ultimate-heading-553969e9fa8ce376a\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-553969e9fa8ce376a uvc-1195 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-553969e9fa8ce376a h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-553969e9fa8ce376a .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of August 31, 2020. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to the General Meeting of August 31, 2020.<\/p>\n<p><\/div><\/div><div id=\"ultimate-heading-928069e9fa8ce37d7\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-928069e9fa8ce37d7 uvc-8679 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-928069e9fa8ce37d7 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-928069e9fa8ce37d7 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis-R\u00e9union-BALO_27-07-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Convocation_AGOE_31-08-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_2\u00e8me-\u00e9preuve-BALO-annonce-2003917.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholders (3rd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO_3\u00e8me-convocation.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice of postponement<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO-annonce-2004344.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Texte-des-projets-de-r\u00e9solutions-AGM-31-08-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON general meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2019 Company report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-de-gestion-2019-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2019 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-comptes-sociaux-31-12-19.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2019 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-comptes-conso-31-12-19.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-61169e9fa8ce3853\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-61169e9fa8ce3853 uvc-6444 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-61169e9fa8ce3853 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-61169e9fa8ce3853 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON\u00a0 parent Company accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EUROPLASMA-2019-RCA-CoCAC-26.04.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on consolidated accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EUROPLASMA-2019-RCC-26.04.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON regulated agreements<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EUROPLASMA-2019-RS-CoCAC-26.04.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b06<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_6\u00e8me-r\u00e9solution_Emission-actions-et-VM-supp-DPS-au-profit-de-cat\u00e9gories-du.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b07<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_7\u00e8me-r\u00e9solution_Emission-actions-et-VM-supp-DPS-au-profit-de-cat\u00e9gories-de-.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on resolution n\u00b08<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_8\u00e8me-r\u00e9solution_augmentation-de-capitaml-adh\u00e9rents-PEE_31.07.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b09<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_9\u00e8me-r\u00e9solution_r\u00e9duction-de-capital-par-annulation-dactions-Art-L.225.20.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-314869e9fa8ce38d2\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-314869e9fa8ce38d2 uvc-965 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-314869e9fa8ce38d2 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-314869e9fa8ce38d2 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy (valid for the second call)<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-par-correspondance-AG-EUROPLASMA-du-31.08.20.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_22-09-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS of the General meeting (ordinary part)<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/RESULTAT-CONSOLIDE-DU-VOTE-RESOLUTION-PAR-RESOLUTION_AGO.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting HELD on 31\/08\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/200831-EP-PV-AGM.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting held on 22\/09\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/200922-EP-PV-AG-internet.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting &#8211; 06\/04\/2020 reconvened on 27\/04\/2020&#8243; tab_id=&#8221;1582882626346-12-2&#8243;]<div id=\"ultimate-heading-856869e9fa8ce393e\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-856869e9fa8ce393e uvc-6798 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-856869e9fa8ce393e h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-856869e9fa8ce393e .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<p style=\"text-align: left;\">In the context of the Covid-19 epidemic and in accordance with the measures taken by the government to stop the virus epidemic, the Board of Directors decided to exceptionally hold the general meeting behind closed doors.<\/p>\n<p style=\"text-align: left;\">Shareholders are therefore invited to submit their questions in writing to <a href=\"mailto:contact@europlasma.com\">contact@europlasma.com<\/a> and to use distance voting means. The practical details are specified in the <a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20200406_Compte-rendu-AGE-Europlasma.pdf\">press release dated April 6, 2020.<\/a> (in French)<\/p>\n<p style=\"text-align: left;\">The proxy or postal voting forms received by the company for the meeting of April 6, 2020 remain valid for the meeting of April 27, 2020. For shares held in bearer form, a new conforming bank certificate must be provided.<\/p>\n<p><\/div><\/div><div id=\"ultimate-heading-846569e9fa8ce39aa\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-846569e9fa8ce39aa uvc-4802 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-846569e9fa8ce39aa h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-846569e9fa8ce39aa .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis-r\u00e9union_AGE_06-04-2020-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis-de-convocation-AGE-06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/2\u00e8me-Epreuve-BALO.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Texte-des-resolutions-AGE-06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CA_AGE-06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-679769e9fa8ce3a15\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-679769e9fa8ce3a15 uvc-5379 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-679769e9fa8ce3a15 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-679769e9fa8ce3a15 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON\u00a0 Resolution N\u00b01<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-06-AVRIL-2020-R\u00e9solution-n\u00b01.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on resolution n\u00b02<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-AGE-6-04-2020-Rapport-des-cac-sur-le-regroupement-dactions-non-admises-aux-n\u00e9gociations-sur-un-march\u00e9-reglement\u00e9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON Resolution n\u00b03<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-06-AVRIL-2020-R\u00e9solution-n\u00b03.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b04<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-6-AVRIL-2020-R\u00e9solution-\u00b04.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b0<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-06-AVRIL-2020-R\u00e9solution-n\u00b05.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-579169e9fa8ce3a82\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-579169e9fa8ce3a82 uvc-5981 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-579169e9fa8ce3a82 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-579169e9fa8ce3a82 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-universel-AGE-EUROPLASMA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting on 06\/04\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20200406_PRESENTATION_AG_06-04-2020-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">presentation showed during the general meeting on 27\/04\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PRESENTATION_AG_27-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS of the EGM<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultats-du-vote-r\u00e9solution-par-r\u00e9solution_AGE-27-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the EGM of 6 april 2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV-carence_AGE_06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Mintues of the EGM of 27 APRIL 2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV-AGE_27-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary General Meeting &#8211; 29\/11\/2019 reconvened on 20\/12\/2019&#8243; tab_id=&#8221;1571835876126-11-4&#8243;]<div id=\"ultimate-heading-960269e9fa8ce3b04\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-960269e9fa8ce3b04 uvc-9562 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-960269e9fa8ce3b04 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-960269e9fa8ce3b04 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-AVIS-DE-REUNION_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_avis-convocation_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_avis-de-seconde-convocation_BALO-du-09_12_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-et-Texte-des-Resolutions_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/191113-EP-RG-int%C3%A9grant-rapp.-gvt-entreprise.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON OGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_du_CA_\u00e0_l_AGO_29_11_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on issuance of convertible bonds in favor ehgos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_rapport_compl%C3%A9mentaire_%C3%A9mission_conversion_T4-081119.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on issuance of convertible bonds with warrants attached in favour ehgos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_Rapport_compl%C3%A9mentaire_CA_BEOCABSA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on zigi capital debt compensation<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_rapport_compl%C3%A9mentaire___cr%C3%A9ance_obligataire-081119.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on issuance of convertible bonds in favor zigi capital<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_rapport_compl%C3%A9mentaire_CA_-_Zigi-081119.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">fy2018 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-aux-comptes-annuels-Europlasma-au-31-12-18-DEF.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">fy2018 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-conso-31-12-18-DEF.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-569369e9fa8ce3b72\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-569369e9fa8ce3b72 uvc-6395 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-569369e9fa8ce3b72 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-569369e9fa8ce3b72 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON\u00a0 FY2018 ANNUAL ACCOUNTS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RCA-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON FY2018 CONSOLIDATED ACCOUNTS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2019\/11\/EUROPLASMA-Rapport-des-CAC-Cptes-Consolides-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">special report on\u00a0 regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RS-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on zigi capital debt compensation<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-COMPENSATION-CREANCE-ZIGI-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on convertible bonds issuance in favor of eghos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-OCA-ABO-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on issuance of convertible bonds with warrants attached in favor of ehgos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-OCABSA-ABO-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on convertible bonds issuance in favor of zigi capital<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-OCABSA-ZIGI-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">cERTIFICATION OF REMUNERATIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-ATTESTATION-REMUNERATIONS-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-304269e9fa8ce3bde\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-304269e9fa8ce3bde uvc-1689 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-304269e9fa8ce3bde h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-304269e9fa8ce3bde .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-de-lAGO-dEUROPLASMA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">written questions<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-AG-29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting on 20\/12\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/191119PRESENTATION_AG_20-12-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS of the meeting held on 20\/12\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the OGM on 20\/12\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_PV_AG_20_12_2019_executed.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">minuteS OF THE ogm on 29\/11\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_PV_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary and extraordinary General Meeting of Shareholders &#8211; 20\/08\/2019 reconvened on 03\/09\/2019&#8243; tab_id=&#8221;1562060415991-10-2&#8243;]<div id=\"ultimate-heading-506969e9fa8ce3c4b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-506969e9fa8ce3c4b uvc-3711 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-506969e9fa8ce3c4b h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-506969e9fa8ce3c4b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_ARAC-BALO-du-15-juillet-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis_de_convocation_AGOE_20_08_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/annonce-1904216.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Texte_des_resolutions_AGOE_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Expos\u00e9_sommaire_AGOE_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_du_CA_AGOE_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-893869e9fa8ce3cb9\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-893869e9fa8ce3cb9 uvc-6071 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-893869e9fa8ce3cb9 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-893869e9fa8ce3cb9 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON 4th RESOLUTION<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-Rapport-r\u00e9duction-capital-4\u00e8me-r\u00e9so.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON 6th and 9th RESOLUTIONs<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-260719-Rapport-Co-Cac-R\u00e9solutions-6-et-9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 6th, 7th and 9th resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-260719-RAPPORT-CO-CAC-offre-au-public-r\u00e9sos-6-7-et-9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 6th, 8th and 9th resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-200819-Rapport-Co-Cac-r\u00e9solutions-6-8-et-9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 10th resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-200819-Rapport-Co-Cac-R\u00e9solution-10.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 6th and 11th resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-200819-Rapport-Co-Cac-R\u00e9solution-6-et-11.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-969469e9fa8ce3d26\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-969469e9fa8ce3d26 uvc-1198 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-969469e9fa8ce3d26 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-969469e9fa8ce3d26 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_formulaire-de-vote-par-correspondance.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"http:\/\/&lt;i class=&quot;fa fa-download&quot; aria-hidden=&quot;true&quot;&gt;&lt;\/i&gt;\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">quorum details of the meeting held on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/quorum-d\u00e9finitif.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">RESULTS OF THE ogm held on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/r\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minute of the OGM held on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AGEO_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the general meeting on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PRESENTATION_AG_03-09-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">quorum details of the meeting held on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_-_Quorum_d\u00e9finitif_03_09_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">results of the egm held on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_-_R\u00e9sultat_consolid\u00e9_du_vote_r\u00e9solution_par_r\u00e9solution_-_03_09_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minute of the EGM held on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AGE_03-09-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordianry General Meeting of Shareholders &#8211; 25 February 2019&#8243; tab_id=&#8221;1528192625002-9-7&#8243;]<div id=\"ultimate-heading-544769e9fa8ce3d92\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-544769e9fa8ce3d92 uvc-744 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-544769e9fa8ce3d92 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-544769e9fa8ce3d92 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/BALO-epreuve-annonce-1900040.pdf\" target=\"_blank\" rel=\"noopener\">Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-184169e9fa8ce3dfd\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-184169e9fa8ce3dfd uvc-1391 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-184169e9fa8ce3dfd h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-184169e9fa8ce3dfd .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AUDITORS REPORT<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-543469e9fa8ce3e67\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-543469e9fa8ce3e67 uvc-1271 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-543469e9fa8ce3e67 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-543469e9fa8ce3e67 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">How to vote for bearers ?<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of THE genEral meeting<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;General Meeting of Shareholders &#8211; 21 June 2018 reconvened on 27 September 2018&#8243; tab_id=&#8221;1557215380409-10-3&#8243;]<div id=\"ultimate-heading-467769e9fa8ce3ed3\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-467769e9fa8ce3ed3 uvc-3611 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-467769e9fa8ce3ed3 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-467769e9fa8ce3ed3 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/AVIS_REUNION_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (2nd CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-BALO-2de-convocation-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-Texte_Resolutions_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Expose_Sommaire_AG-21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CA_AGE_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">&#8220;dOCUMENT DE R\u00c9F\u00c9RENCE&#8221; 2017 including the annual financial report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/DDR2017ALEUP.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-600969e9fa8ce3f40\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-600969e9fa8ce3f40 uvc-6660 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-600969e9fa8ce3f40 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-600969e9fa8ce3f40 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Certificatie ON REmuneration<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-Attestation-CAC-r\u00e9mun\u00e9rations-vers\u00e9es.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b09<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s9-Rapport-CAC-r\u00e9duction-capital.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b011 and n\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s11-15-Rapport-CAC-\u00e9mission-actions-et-VM-maintien-DPS.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b014 and n\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s14-15-Rapport-CAC-\u00e9mission-actions-et-VM-supp-DPS-au-profit-de-categories-de-b\u00e9n\u00e9ficiaires.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b012 and n\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s12-15-Rapport-CAC-\u00e9mission-actions-et-VM-supp-DPS-offre-au-public.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b014 and N\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s14-15-Rapport-CAC-\u00e9mission-actions-et-VM-supp-DPS-au-profit-de-categories-de-b\u00e9n\u00e9ficiaires.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b0 16<\/td>\n<td style=\"text-align: right;\">\u00a0<a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s16-Rapport-CAC-aug-capital-r\u00e9serv\u00e9e-aux-adh\u00e9rent-PEE.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-819469e9fa8ce3fad\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-819469e9fa8ce3fad uvc-8666 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-819469e9fa8ce3fad h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-819469e9fa8ce3fad .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_formlulaire-de-vote-par-correspondance.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">How to vote for bearers ?<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Procedure-vote-actionnaires-au-porteur-AG-21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">JEAN-ERIC PETIT PROFILE<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/CV_JEP_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">francois bonnin profile<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/CV-Fran\u00e7ois-Bonnin.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">olivier ricart profile<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/CV_O-RICART.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Answers to written questions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Reponses-Questions-ecrites_AG-27-09-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 21\/06\/2018<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of general meeting of 27\/09\/2018<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AG_27-09-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;General Meeting of Shareholders &#8211; 10\/10\/2017 reconvened on 26\/10\/2017&#8243; tab_id=&#8221;1505204903962-7-0&#8243;]<div id=\"ultimate-heading-889469e9fa8ce4018\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-889469e9fa8ce4018 uvc-8532 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-889469e9fa8ce4018 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-889469e9fa8ce4018 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/avis_reunion_balo_04-09-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/1704518_epreuve_1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (2ND CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-2eme-convocation.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_TR_AGE_10-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_Rppt_AGE_activite.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-800569e9fa8ce4089\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-800569e9fa8ce4089 uvc-8338 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-800569e9fa8ce4089 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-800569e9fa8ce4089 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION n\u00b01<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolution_1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b03 and 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_3-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b04 and 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_4-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b05 to 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_5-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b06 to 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_6-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b07 to 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_7-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b0 9<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolution_9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-285469e9fa8ce40f6\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-285469e9fa8ce40f6 uvc-8765 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-285469e9fa8ce40f6 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-285469e9fa8ce40f6 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_Formulaire-de-vote-vierge.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">How to vote for bearers ?<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Porc\u00e9dure-vote-actionnaires-au-porteur-AGE-oct-2017_DEF.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">THE COMPANY DECIDES NOT TO COMPLY WITH A REQUEST FOR REGISTRATION OF A DRAFT RESOLUTION, THE LEGAL CONDITIONS HAVE NOT BEEN MET. HOWEVER, THE COMPANY WISHES TO REPLY IN COMPLETE AND DETAILED MANNER AND TO PUT THE CONTENT OF ITS RESPONSE ON-LINE IN THE INTERESTS OF ALL SHAREHOLDERS.<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Reponse_courrier_actionnaire.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Answers to questions from shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-R\u00e9ponses_AGE_26-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PRESENTATION_AGE_26-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 26\/10\/2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/RESULTATS_AGE-26-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minute of General Meeting of 10 October 2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-PV-AGE-DE-CARENCE-10-octobre-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary and extraordinary General Meeting of Shareholders &#8211; 15\/06\/2017 reconvened on 29\/06\/2017&#8243; tab_id=&#8221;1504002901701-6-9&#8243;]<div id=\"ultimate-heading-302069e9fa8ce4163\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-302069e9fa8ce4163 uvc-6716 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-302069e9fa8ce4163 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-302069e9fa8ce4163 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_avis_reunion_ag_ep_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Corrigendum to the notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_avis_convocation_ag_ep_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareloders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/texte-resolutions-2012.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of Resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/texte_reso_ag_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/expose_sommaire_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report of Board of Directors of the OGM\/EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_ca_age_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2016 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/compte_sociaux_31-12-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2016 consolidated account<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_conso_31-12-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2016 Registration Document including Financial Annual Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ddr_2016_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-126869e9fa8ce41d1\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-126869e9fa8ce41d1 uvc-6419 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-126869e9fa8ce41d1 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-126869e9fa8ce41d1 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2016 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_cptes-annuels_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2016 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_cptes-conso_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_spe_conventions-reglementees_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Complementary report on the issue of OCABSA<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_complementaire_cac_ocabsa.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution n\u00b07<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_7.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution 10 to 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_10-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution\u00a011 to 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_11-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution 12 to 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_12-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution 13 and 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_13-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution\u00a015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_15.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-220069e9fa8ce423e\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-220069e9fa8ce423e uvc-9787 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-220069e9fa8ce423e h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\"> OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-220069e9fa8ce423e .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy (valid for the AGM of 29\/06\/2017)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_vpc_agm15-06-17_vierge.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Erik Martel profile<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/erik_martel_curriculum_vitae.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Answers to questions from shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/questions-rponses_ag_29-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_29-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 15 June 2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/pv_agep_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 29 June 2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_pv_ago_29-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting &#8211; 02\/09\/2016&#8243; tab_id=&#8221;1503670629-2-27&#8243;]<div id=\"ultimate-heading-42869e9fa8ce42aa\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-42869e9fa8ce42aa uvc-2473 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-42869e9fa8ce42aa h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-42869e9fa8ce42aa .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_age_27-07-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/avis_convocation_age_12-08-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of Resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/age_texte-resolution_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report of Board of Directors to the EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_ca_age_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_recto-verso_europlasma-02_09_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-29269e9fa8ce4316\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-29269e9fa8ce4316 uvc-4966 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-29269e9fa8ce4316 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-29269e9fa8ce4316 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on 1st Resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_reso1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on 2nd Resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_reso2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on 3rd Resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_reso3.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-557969e9fa8ce4381\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-557969e9fa8ce4381 uvc-7467 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-557969e9fa8ce4381 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-557969e9fa8ce4381 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_ag.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation\u00a0showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">General meeting results<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/pv_age_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Combined General Meeting &#8211; 08\/06\/2016&#8243; tab_id=&#8221;1503670629-1-82&#8243;]<div id=\"ultimate-heading-261669e9fa8ce43ee\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-261669e9fa8ce43ee uvc-3853 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-261669e9fa8ce43ee h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-261669e9fa8ce43ee .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_avis_reunion_ag_08-06-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_ag_ep_13-05-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of Resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/texte_resolutions_agoe2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/expose_sommaire_ag2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report of Board of Directors to the OGM\/EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_president_age2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2015\u00a0parent company\u00a0accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_sociaux_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY 2015 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_consolides_2015_28-04-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2015 Registration Document\u00a0including\u00a0Financial Annual Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_ddr_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-861769e9fa8ce445b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-861769e9fa8ce445b uvc-1716 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-861769e9fa8ce445b h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-861769e9fa8ce445b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2015\u00a0parent company\u00a0accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/aleup_rapport_cac_comptes_annuels_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2015 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/aleup_rapport_cac_comptes_consolides_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/aleup_rapport_cac_conventions_reglementees_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the share capital reduction (9th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_rapport_cac_reduction_capital.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the issuing of bonus shares (10th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_rapport_attribution_actions.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the issuing of warrants with subscription rights cancelled (11th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_rapport_sup_dps.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on issuing of stock options and\/or subscription plan (12th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_options_souscription.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the issuing of common shares reserved to PEE (13th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_augmentation_capital_pee.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-903369e9fa8ce44c8\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-903369e9fa8ce44c8 uvc-7189 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-903369e9fa8ce44c8 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-903369e9fa8ce44c8 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_vpc.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Pierre Catlin&#8217;s biography<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/cv_pierre_catlin.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Yann Le Dor\u00e9&#8217;s biography<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/cv_yann_le_dore.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_ag-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation\u00a0showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">General meeting results<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/resultats_agm_08-06-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Combined General Meeting &#8211; 24\/06\/2015&#8243; tab_id=&#8221;1503999928284-3-4&#8243;]<div id=\"ultimate-heading-677569e9fa8ce453b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-677569e9fa8ce453b uvc-8998 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-677569e9fa8ce453b h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-677569e9fa8ce453b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_13_mai_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/odj_texte_reso_ag2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/avis_convocation.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/expose_sommaire_ag2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Financial results over 5 years (parent company)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/tableau_resultats_5exercices.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2014 report of activity<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_activite_aleup.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Board of Directors report on OGM\/EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_ag_24-06-2015vdef.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2014 annual accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_sociaux_2014_aleup.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2014 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_consolides_2014_aleup.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-508869e9fa8ce45a9\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-508869e9fa8ce45a9 uvc-7030 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-508869e9fa8ce45a9 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-508869e9fa8ce45a9 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Information note on the reports<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/note_information.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2014 social accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_comptes_sociaux_2014.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2014 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_comptes_conso_2014.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_spe_cac_conv_reg_2014.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the capital reduction<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapp_cac_reduction_k.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the capital increases with preferential rights maintained<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapp_cac_augmentations_k.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the allocation of bonus shares<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_aga.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the capital increase reserved for employees<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapp_cac_aug_k_salaries.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-998969e9fa8ce4624\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-998969e9fa8ce4624 uvc-5085 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-998969e9fa8ce4624 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-998969e9fa8ce4624 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_recto_verso_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_ag-2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_24-06-2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Questions and answers during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/qa_agoe_24-06-2015_vdef.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">General Meeting results<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_resultats_agoe_24-06-2015b.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1536,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-invest.php","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/2138"}],"collection":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/comments?post=2138"}],"version-history":[{"count":174,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/2138\/revisions"}],"predecessor-version":[{"id":2795,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/2138\/revisions\/2795"}],"up":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/1536"}],"wp:attachment":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/media?parent=2138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}